Agenus | AGEN - Market Capitalization


Agenus reported $1.34B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 40M 24M Mar/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
CSL USD 71.32B 15.44B Mar/2026
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 86.88B 7.29B Sep/2025
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Jiangsu Hengrui CNY 477.39B 133.64B Sep/2025
MacroGenics USD 106M 29M Sep/2025
Merck EUR 50.48B 2.89B Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Veracyte USD 3.33B 627M Dec/2025